This Article Full Text Full Text (PDF) Other Versions of this Article: JCM.01325-06v1 45/2/604    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Goodrich, J. S. Articles by Miller, M. B. Search for Related Content PubMed PubMed Citation Articles by Goodrich, J. S. Articles by Miller, M. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2007, p. 604-606, Vol. 45, No. 2
0095-1137/07/$08.00+0     doi:10.1128/JCM.01325-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Comparison of Cepheid's Analyte-Specific Reagents with BD Directigen for Detection of Respiratory Syncytial Virus

University of North Carolina Hospitals, Clinical Microbiology-Immunology Laboratory,¹ University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina²

Received 27 June 2006/ Returned for modification 10 October 2006/ Accepted 7 December 2006

For detection of respiratory syncytial virus (RSV), the BD Directigen RSV rapid antigen assay was compared to Cepheid's real-time reverse transcriptase PCR RSV analyte-specific reagents. The Directigen RSV assay resulted in a 23% false-negative rate, using PCR and chart review as the gold standard, indicating that rapid RSV PCR results would be advantageous.

Published ahead of print on 20 December 2006.